Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT.

Glanville AR, Verleden GM, Todd JL, Benden C, Calabrese F, Gottlieb J, Hachem RR, Levine D, Meloni F, Palmer SM, Roman A, Sato M, Singer LG, Tokman S, Verleden SE, von der Thüsen J, Vos R, Snell G.

J Heart Lung Transplant. 2019 May;38(5):483-492. doi: 10.1016/j.healun.2019.03.008. Epub 2019 Apr 3. No abstract available.

PMID:
31027539
2.

Development and Optimization of an ELISA to Quantitate C3(H 2 O) as a Marker of Human Disease.

Elvington M, Liszewski MK, Liszewski AR, Kulkarni HS, Hachem RR, Mohanakumar T, Kim AHJ, Atkinson JP.

Front Immunol. 2019 Apr 4;10:703. doi: 10.3389/fimmu.2019.00703. eCollection 2019.

3.

The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches.

Hachem RR.

Hum Immunol. 2019 Apr 17. pii: S0198-8859(19)30141-7. doi: 10.1016/j.humimm.2019.04.008. [Epub ahead of print] Review.

PMID:
31005400
4.

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.

Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R.

J Heart Lung Transplant. 2019 May;38(5):493-503. doi: 10.1016/j.healun.2019.03.009. Epub 2019 Apr 3. No abstract available.

PMID:
30962148
5.

Chest computed tomography imaging improves potential lung donor assessment.

Gauthier JM, Bierhals AJ, Liu J, Balsara KR, Frederiksen C, Gremminger E, Hachem RR, Witt CA, Trulock EP, Byers DE, Yusen RD, Aguilar PR, Marklin G, Nava RG, Kozower BD, Pasque MK, Meyers BF, Patterson GA, Kreisel D, Puri V.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1711-1718.e1. doi: 10.1016/j.jtcvs.2018.11.038. Epub 2018 Nov 24.

PMID:
30772037
6.

Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.

Tague LK, Witt CA, Byers DE, Yusen RD, Aguilar PR, Kulkarni HS, Bain KB, Fester KA, Puri V, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR.

Ann Am Thorac Soc. 2019 Feb 14. doi: 10.1513/AnnalsATS.201810-713OC. [Epub ahead of print]

PMID:
30763122
7.

Unintended consequences of changes to lung allocation policy.

Puri V, Hachem RR, Frye CC, Harrison MS, Semenkovich TR, Lynch JP, Ridolfi G, Rowe C, Meyers BF, Patterson GA, Kozower BD, Pasque MK, Nava RG, Marklin GF, Brockmeier D, Sweet SC, Chapman WC, Kreisel D.

Am J Transplant. 2019 Feb 13. doi: 10.1111/ajt.15307. [Epub ahead of print]

PMID:
30758137
8.

Technical Considerations for Lung Transplantation in Kartagener's Syndrome.

Gauthier JM, Takahashi T, Bierhals AJ, Brody SL, Hachem RR, Witt CA, Byers DE, Yusen RD, Trulock EP, Aguilar PR, Nava RG, Kozower BD, Meyers BF, Patterson GA, Kreisel D, Puri V.

Ann Thorac Surg. 2019 May;107(5):e337-e339. doi: 10.1016/j.athoracsur.2018.08.095. Epub 2018 Oct 26.

PMID:
30612988
9.

Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection.

Li W, Gauthier JM, Higashikubo R, Hsiao HM, Tanaka S, Vuong L, Ritter JH, Tong AY, Wong BW, Hachem RR, Puri V, Bharat A, Krupnick AS, Hsieh CS, Baldwin WM 3rd, Kelly FL, Palmer SM, Gelman AE, Kreisel D.

J Clin Invest. 2019 Feb 1;129(2):556-568. doi: 10.1172/JCI122083. Epub 2018 Dec 18.

10.

Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.

Kulkarni HS, Cherikh WS, Chambers DC, Garcia VC, Hachem RR, Kreisel D, Puri V, Kozower BD, Byers DE, Witt CA, Alexander-Brett J, Aguilar PR, Tague LK, Furuya Y, Patterson GA, Trulock EP 3rd, Yusen RD.

J Heart Lung Transplant. 2019 Jan;38(1):5-16. doi: 10.1016/j.healun.2018.09.016. Epub 2018 Sep 25.

PMID:
30391193
11.

National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.

Mulligan MS, Weill D, Davis RD, Christie JD, Farjah F, Singer JP, Hartwig M, Sanchez PG, Kreisel D, Ware LB, Bermudez C, Hachem RR, Weyant MJ, Gries C, Awori Hayanga JW, Griffith BP, Snyder LD, Odim J, Craig JM, Aggarwal NR, Reineck LA.

J Thorac Cardiovasc Surg. 2018 Dec;156(6):2355-2365. doi: 10.1016/j.jtcvs.2018.08.010. Epub 2018 Aug 18. No abstract available.

PMID:
30244865
12.

Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.

Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ.

Transplantation. 2019 May;103(5):1036-1042. doi: 10.1097/TP.0000000000002430.

PMID:
30130331
13.

Transplantation of Lungs Procured From a Donor With an Atrioesophageal Fistula.

Takahashi T, Gauthier JM, Albertin EK, Damiano RJ Jr, Patterson GA, Bierhals AJ, Pasque MK, Hachem RR, Puri V, Kreisel D.

Ann Thorac Surg. 2019 Feb;107(2):e121-e122. doi: 10.1016/j.athoracsur.2018.06.049. Epub 2018 Aug 3.

PMID:
30081029
14.

Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.

Hachem RR, Kamoun M, Budev MM, Askar M, Ahya VN, Lee JC, Levine DJ, Pollack MS, Dhillon GS, Weill D, Schechtman KB, Leard LE, Golden JA, Baxter-Lowe L, Mohanakumar T, Tyan DB, Yusen RD.

Am J Transplant. 2018 Sep;18(9):2285-2294. doi: 10.1111/ajt.14893. Epub 2018 May 15.

PMID:
29687961
15.

Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.

Gauthier JM, Ruiz-Pérez D, Li W, Hachem RR, Puri V, Gelman AE, Kreisel D.

Transplantation. 2018 Sep;102(9):1459-1466. doi: 10.1097/TP.0000000000002250. Review.

PMID:
29683998
16.

Immunosuppression: Have We Learnt Anything?

Hachem RR.

Semin Respir Crit Care Med. 2018 Apr;39(2):172-180. doi: 10.1055/s-0037-1615798. Epub 2018 Mar 26. Review.

PMID:
29579769
17.

Acute graft-versus-host disease following lung transplantation in a patient with a novel TERT mutation.

Brestoff JR, Vessoni AT, Brenner KA, Uy GL, DiPersio JF, Blinder M, Witt CA, Byers DE, Hachem RR, Truclock EP, Early DS, Anadkat MJ, Musiek A, Javidan-Nejad C, Balfe DM, Rosman IS, Liu C, Zhang L, Despotis GJ, Ruzinova MB, Sehn JK, Amarillo I, Heusel JW, Swat W, Kim BS, Wartman LD, Yusen RD, Batista LFZ.

Thorax. 2018 May;73(5):489-492. doi: 10.1136/thoraxjnl-2017-211121. Epub 2018 Jan 30.

18.

Acute Rejection and Antibody-Mediated Rejection in Lung Transplantation.

Hachem RR.

Clin Chest Med. 2017 Dec;38(4):667-675. doi: 10.1016/j.ccm.2017.07.008. Epub 2017 Sep 1. Review.

PMID:
29128017
19.

The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.

Aguilar PR, Carpenter D, Ritter J, Yusen RD, Witt CA, Byers DE, Mohanakumar T, Kreisel D, Trulock EP, Hachem RR.

Am J Transplant. 2018 Apr;18(4):936-944. doi: 10.1111/ajt.14534. Epub 2017 Nov 11.

20.

Extracorporeal photopheresis for the management of lung allograft rejection.

Witt CA, Hachem RR.

Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13084. Epub 2017 Aug 29. No abstract available.

PMID:
28853182
21.

Impact of Delayed Chest Closure on Surgical Site Infection After Lung Transplantation.

Aguilar PR, Bemiss BC, Witt C, Byers DE, Kreisel D, Puri V, Meyers B, Patterson GA, Krupnick AS, Yusen RD, Trulock EP, Hachem RR.

Ann Thorac Surg. 2017 Oct;104(4):1208-1214. doi: 10.1016/j.athoracsur.2017.05.023. Epub 2017 Aug 16.

PMID:
28821338
22.

Update on Chronic Lung Allograft Dysfunction.

Gauthier JM, Hachem RR, Kreisel D.

Curr Transplant Rep. 2016 Sep;3(3):185-191. doi: 10.1007/s40472-016-0112-y. Epub 2016 Aug 2.

23.

Antibody-mediated Rejection in Lung Transplantation.

Kulkarni HS, Bemiss BC, Hachem RR.

Curr Transplant Rep. 2015 Dec;2(4):316-323. Epub 2015 Sep 30.

24.

Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients.

Sofjan AK, Iuppa JA, Bain KB, Deal EN, Witt CA, Hachem RR, Yusen RD.

Ann Pharmacother. 2016 Oct;50(10):824-31. doi: 10.1177/1060028016656434. Epub 2016 Jun 29.

PMID:
27363845
25.

Humoral responses after lung transplantation.

Hachem RR.

Curr Opin Organ Transplant. 2016 Jun;21(3):267-71. doi: 10.1097/MOT.0000000000000308. Review.

PMID:
26967997
26.

Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience.

Chen C, Bain KB, Iuppa JA, Yusen RD, Byers DE, Patterson GA, Trulock EP, Hachem RR, Witt CA.

Transplantation. 2016 Mar;100(3):678-84. doi: 10.1097/TP.0000000000000868.

PMID:
26335916
27.

The impact of pre-transplant allosensitization on outcomes after lung transplantation.

Bosanquet JP, Witt CA, Bemiss BC, Byers DE, Yusen RD, Patterson AG, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2015 Nov;34(11):1415-22. doi: 10.1016/j.healun.2015.06.003. Epub 2015 Jun 10.

28.

What is the definition of a clinically relevant donor HLA-specific antibody (DSA)?

Hachem RR, Reinsmoen NL.

Am J Transplant. 2015 Feb;15(2):299-300. doi: 10.1111/ajt.13079. No abstract available.

29.

Advancing Lung Transplantation.

Hachem RR.

Clin Transpl. 2015;31:239-247.

PMID:
28514585
30.

Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.

Ibrahim M, Wang X, Puyo CA, Montecalvo A, Huang HJ, Hachem RR, Andreetti C, Menna C, Chen R, Krupnick AS, Kreisel D, Rendina EA, Gelman AE.

J Heart Lung Transplant. 2015 Feb;34(2):247-53. doi: 10.1016/j.healun.2014.09.034. Epub 2014 Oct 2.

31.

Acute antibody-mediated rejection after lung transplantation.

Witt CA, Gaut JP, Yusen RD, Byers DE, Iuppa JA, Bennett Bain K, Alexander Patterson G, Mohanakumar T, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2013 Oct;32(10):1034-40. doi: 10.1016/j.healun.2013.07.004. Epub 2013 Aug 13.

32.

Immunosuppression: what's standard and what's new?

Witt CA, Hachem RR.

Semin Respir Crit Care Med. 2013 Jun;34(3):405-13. doi: 10.1055/s-0033-1348465. Epub 2013 Jul 2. Review.

PMID:
23821513
33.

Pulmonary infections following lung transplantation.

Witt CA, Meyers BF, Hachem RR.

Thorac Surg Clin. 2012 Aug;22(3):403-12. doi: 10.1016/j.thorsurg.2012.04.006. Epub 2012 Jun 13. Review.

PMID:
22789602
34.

Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.

Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T.

Am J Transplant. 2012 Aug;12(8):2164-71. doi: 10.1111/j.1600-6143.2012.04079.x. Epub 2012 May 8.

35.

Antibodies to human leukocyte antigens in lung transplantation.

Hachem RR.

Clin Transpl. 2011:327-32. Review.

PMID:
22755426
36.

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation.

Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP.

J Heart Lung Transplant. 2010 Sep;29(9):973-80. doi: 10.1016/j.healun.2010.05.006. Epub 2010 Jun 16.

37.

Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.

Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ.

J Heart Lung Transplant. 2010 May;29(5):531-7. doi: 10.1016/j.healun.2009.12.003. Epub 2010 Feb 4.

38.

Lung transplantation at Barnes-Jewish Hospital and Washington University in St. Louis.

Hachem RR, Patterson GA, Trulock EP.

Clin Transpl. 2010:227-34.

PMID:
21696044
39.

Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.

Golocheikine A, Nath DS, Basha HI, Saini D, Phelan D, Aloush A, Trulock EP, Hachem RR, Patterson GA, Ahearn JM, Mohanakumar T.

J Heart Lung Transplant. 2010 Apr;29(4):410-6. doi: 10.1016/j.healun.2009.10.003.

40.

The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.

Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2010 Apr;29(4):424-31. doi: 10.1016/j.healun.2009.08.029. Epub 2009 Oct 22.

PMID:
19853479
41.

Lung allograft rejection: diagnosis and management.

Hachem RR.

Curr Opin Organ Transplant. 2009 Oct;14(5):477-82. doi: 10.1097/MOT.0b013e32832fb981. Review.

PMID:
19617825
42.

Clinical outcomes of solid organ transplant recipients with ehrlichiosis.

Lawrence KL, Morrell MR, Storch GA, Hachem RR, Trulock EP.

Transpl Infect Dis. 2009 Jun;11(3):203-10. doi: 10.1111/j.1399-3062.2009.00373.x. Epub 2009 Feb 18. Review.

PMID:
19228344
43.

Acute antibody-mediated rejection after lung transplantation.

Morrell MR, Patterson GA, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2009 Jan;28(1):96-100. doi: 10.1016/j.healun.2008.09.013. Epub 2008 Dec 4.

PMID:
19134538
44.

Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.

Huang HJ, Yusen RD, Meyers BF, Walter MJ, Mohanakumar T, Patterson GA, Trulock EP, Hachem RR.

Am J Transplant. 2008 Nov;8(11):2454-62. doi: 10.1111/j.1600-6143.2008.02389.x. Epub 2008 Sep 10.

45.

The new lung allocation system and its impact on waitlist characteristics and post-transplant outcomes.

Hachem RR, Trulock EP.

Semin Thorac Cardiovasc Surg. 2008 Summer;20(2):139-42. doi: 10.1053/j.semtcvs.2008.04.004. Review.

PMID:
18707648
46.

Thrombotic microangiopathy after lung transplantation: a difficult diagnosis.

Hachem RR.

South Med J. 2008 Jul;101(7):683-4. doi: 10.1097/SMJ.0b013e318179a2d8. No abstract available.

PMID:
18580730
47.

The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.

Hachem RR, Edwards LB, Yusen RD, Chakinala MM, Alexander Patterson G, Trulock EP.

Clin Transplant. 2008 Sep-Oct;22(5):603-8. doi: 10.1111/j.1399-0012.2008.00831.x. Epub 2008 Apr 23.

PMID:
18435784
48.

A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.

Hachem RR, Yusen RD, Chakinala MM, Meyers BF, Lynch JP, Aloush AA, Patterson GA, Trulock EP.

J Heart Lung Transplant. 2007 Oct;26(10):1012-8.

PMID:
17919621
49.

Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.

Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR.

Am J Respir Crit Care Med. 2007 Mar 1;175(5):507-13. Epub 2006 Dec 7.

PMID:
17158279
50.

IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ.

Am J Respir Crit Care Med. 2006 Aug 15;174(4):461-70. Epub 2006 May 25.

Supplemental Content

Loading ...
Support Center